Article Text

Download PDFPDF
12C-glycocholate test in Crohn's disease—its value in assessment and treatment
  1. J. H. B. Scarpello,
  2. G. E. Sladen


    The 14C-glycocholic acid test (14C-GCA) has been assessed in 27 patients who have had resection of the ileum and colon for Crohn's disease and in 19 patients with unoperated stable Crohn's disease. The incidence of increased breath output of 14CO2 and faecal output of 14C was significantly greater in operated patients. Half the unoperated patients had normal results and, of the others, a modest increase in faecal 14C was the usual finding. There was no correlation between the 14C-GCA test, the Schilling test, and the extent and severity of the radiological signs in the unoperated patients. Metronidazole therapy was poorly tolerated and had little or no influence on symptoms but did decrease the excretion of 14CO2 in the breath when the 14C-GCA test was repeated. Cholestyramine therapy was beneficial in the majority of resected patients with diarrhoea and an increased faecal 14C excretion and, on repeat testing, there was a significant increase in the output of breath 14CO2. The beneficial effect was less marked in the unoperated patients and the breath 14CO2 output remained normal in those retested. Interruption of the enterohepatic circulation of bile acids did not seem to make an important contribution to the symptoms of patients with stable unoperated (and uncomplicated) Crohn's disease, even when the ileum was extensively involved.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.